| 1 |
Fraser R, Orta-Resendiz A, Dockrell D, Müller-Trutwin M, Mazein A. Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection. Eur Respir Rev 2023;32:220197. [PMID: 36889788 DOI: 10.1183/16000617.0197-2022] [Reference Citation Analysis]
|
| 2 |
Tatematsu D, Akao M, Park H, Iwami S, Ejima K, Iwanami S. Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors. J Theor Biol 2023;561:111403. [PMID: 36586664 DOI: 10.1016/j.jtbi.2022.111403] [Reference Citation Analysis]
|
| 3 |
Poydenot F, Lebreton A, Haiech J, Andreotti B. At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics. Biochimie 2023:S0300-9084(23)00068-8. [PMID: 36931337 DOI: 10.1016/j.biochi.2023.03.006] [Reference Citation Analysis]
|
| 4 |
Ito K, Daly L, Coates M. An impact of age on respiratory syncytial virus infection in air-liquid-interface culture bronchial epithelium. Front Med 2023;10. [DOI: 10.3389/fmed.2023.1144050] [Reference Citation Analysis]
|
| 5 |
Matsuyama T, Saeki S, Kosaka S, Matsuoka Y, Aoki Y, Itoh Y, Imaeda T. Inactivation of SARS-CoV-2 variants by nitrogen-doped titanium dioxide loaded with metals as visible-light photocatalysts. Biotechnol Lett 2023;:1-11. [PMID: 36913102 DOI: 10.1007/s10529-023-03361-3] [Reference Citation Analysis]
|
| 6 |
Xu J, Carruthers J, Finnie T, Hall I. Simplified within-host and Dose-response Models of SARS-CoV-2. J Theor Biol 2023;:111447. [PMID: 36898624 DOI: 10.1016/j.jtbi.2023.111447] [Reference Citation Analysis]
|
| 7 |
Drain PK, Dalmat RR, Hao L, Bemer MJ, Budiawan E, Morton JF, Ireton RC, Hsiang TY, Marfatia Z, Prabhu R, Woosley C, Gichamo A, Rechkina E, Hamilton D, Montaño M, Cantera JL, Ball AS, Golez I, Smith E, Greninger AL, McElrath MJ, Thompson M, Grant BD, Meisner A, Gottlieb GS, Gale MJ. Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study. J Clin Virol 2023;161:105420. [PMID: 36913789 DOI: 10.1016/j.jcv.2023.105420] [Reference Citation Analysis]
|
| 8 |
Sekine Y, Nakajima K, Otake K, Takizawa T, Sugiyama J, Mukai T, Kakizawa Y, Kurahashi S. Visualization of the Risk and the Care Effects on the Viral Contact Infection in the Home. Transactions of the Japanese Society for Artificial Intelligence 2023;38:B-MA6_1-11. [DOI: 10.1527/tjsai.38-2_b-ma6] [Reference Citation Analysis]
|
| 9 |
Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol 2023;21:147-61. [PMID: 36460930 DOI: 10.1038/s41579-022-00822-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 10 |
Kwon T, Osterrieder N, Gaudreault NN, Richt JA. Fomite Transmission of SARS-CoV-2 and Its Contributing Factors. Pathogens 2023;12:364. [DOI: 10.3390/pathogens12030364] [Reference Citation Analysis]
|
| 11 |
Swadling L, Maini MK. Can T Cells Abort SARS-CoV-2 and Other Viral Infections? Int J Mol Sci 2023;24. [PMID: 36901802 DOI: 10.3390/ijms24054371] [Reference Citation Analysis]
|
| 12 |
Moore KA, Leighton T, Ostrowsky JT, Anderson CJ, Danila RN, Ulrich AK, Lackritz EM, Mehr AJ, Baric RS, Baylor NW, Gellin BG, Gordon JL, Krammer F, Perlman S, Rees HV, Saville M, Weller CL, Osterholm MT; Coronavirus Vaccines R&D Roadmap Taskforce. A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy. Vaccine 2023:S0264-410X(23)00167-6. [PMID: 36870874 DOI: 10.1016/j.vaccine.2023.02.032] [Reference Citation Analysis]
|
| 13 |
Hemken PM, Israeli E, Taylor R, Jacobson C, Datwyler M, Geissler R, Hadji A, Jeanblanc N, Pandya K, Marcinkus M, Piktel R, Bogdan MF, Rodgers M, Anderson M, Ziemann R, Tieman BC, Hawksworth D, Moore J, Otis KS, Marohnic CC, Corby J, Tu B, Lin Z, Kar A, Hartnett J, Strobel C, Gregory S, Rae T, Muerhoff AS, Brophy S, Hackett JR, Daghfal D, Faron ML, Cruz A, Mohr P, Sokoll L, Davis GJ. Pre-analytical considerations in the development of a prototype SARS-CoV-2 antigen ARCHITECT automated immunoassay. Clin Chem Lab Med 2023. [PMID: 36799248 DOI: 10.1515/cclm-2022-1292] [Reference Citation Analysis]
|
| 14 |
Li Y, Harrison LJ, Chew KW, Currier JS, Wohl DA, Daar ES, Evering TH, Wu R, Giganti M, Ritz J, Javan AC, Coombs RW, Moser C, Hughes MD, Eron JJ, Smith DM, Li JZ. Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019. Clin Infect Dis 2023;76:734-7. [PMID: 36210483 DOI: 10.1093/cid/ciac818] [Reference Citation Analysis]
|
| 15 |
Nazareth J, Fahad M, Pareek M; East Midlands Respiratory Virus Research Group. Mitigating the return of acute respiratory virus infections. BMJ 2023;380:352. [PMID: 36787911 DOI: 10.1136/bmj.p352] [Reference Citation Analysis]
|
| 16 |
Gordon SB, Sichone S, Chirwa AE, Hazenberg P, Kafuko Z, Ferreira DM, Flynn J, Fortune S, Balasingam S, Biagini GA, Mcshane H, Mwandumba H, Jambo K, Dedha K, Raj Sharma N, Robertson BD, Walker N, Morton B, TB Controlled Human Infection Model Development Group. Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi. Wellcome Open Res 2023;8:71. [DOI: 10.12688/wellcomeopenres.18767.1] [Reference Citation Analysis]
|
| 17 |
Hong KH, Sung H. SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents. JAMA 2023;329:424-5. [PMID: 36749340 DOI: 10.1001/jama.2022.21596] [Reference Citation Analysis]
|
| 18 |
Pan D, Williams CM, Decker J, Fletcher E, Sze S, Assadi S, Haigh R, Saleem B, Nazareth J, Garton NJ, Pareek M, Barer MR. Exhaled SARS-CoV-2 RNA viral load kinetics measured by facemask sampling associates with household transmission. Clin Microbiol Infect 2023;29:254.e1-6. [PMID: 35843566 DOI: 10.1016/j.cmi.2022.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Cevik M, Kalil AC. Omicron variant: assessing the duration of viral shedding and its implications. Clin Microbiol Infect 2023;29:133-4. [PMID: 36442799 DOI: 10.1016/j.cmi.2022.11.019] [Reference Citation Analysis]
|
| 20 |
Meunier N. [Olfaction and respiratory viruses… A relationship revealed by Covid-19]. Med Sci (Paris) 2023;39:119-28. [PMID: 36799746 DOI: 10.1051/medsci/2023007] [Reference Citation Analysis]
|
| 21 |
Cable J, Sun J, Cheon IS, Vaughan AE, Castro IA, Stein SR, López CB, Gostic KM, Openshaw PJM, Ellebedy AH, Wack A, Hutchinson E, Thomas MM, Langlois RA, Lingwood D, Baker SF, Folkins M, Foxman EF, Ward AB, Schwemmle M, Russell AB, Chiu C, Ganti K, Subbarao K, Sheahan TP, Penaloza-MacMaster P, Eddens T. Respiratory viruses: New frontiers-a Keystone Symposia report. Ann N Y Acad Sci 2023. [PMID: 36722473 DOI: 10.1111/nyas.14958] [Reference Citation Analysis]
|
| 22 |
Abdin AY, De Pretis F, Landes J. Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness. Int J Environ Res Public Health 2023;20. [PMID: 36767769 DOI: 10.3390/ijerph20032404] [Reference Citation Analysis]
|
| 23 |
von Bartheld CS, Wang L. Prevalence of Olfactory Dysfunction with the Omicron Variant of SARS-CoV-2: A Systematic Review and Meta-Analysis. Cells 2023;12. [PMID: 36766771 DOI: 10.3390/cells12030430] [Reference Citation Analysis]
|
| 24 |
Samsunder N, Lustig G, Ngubane S, Maseko TG, Rambaran S, Ngcapu S, Magini SN, lewis L, Cawood C, Kharsany AB, Karim QA, Karim SA, Naidoo K, Sivro A. Field evaluations of four SARS-CoV-2 rapid antigen tests during SARS-CoV-2 Delta variant wave in South Africa.. [DOI: 10.21203/rs.3.rs-2355146/v1] [Reference Citation Analysis]
|
| 25 |
Phan T, Brozak S, Pell B, Gitter A, Xiao A, Mena KD, Kuang Y, Wu F. A simple SEIR-V model to estimate COVID-19 prevalence and predict SARS-CoV-2 transmission using wastewater-based surveillance data. Sci Total Environ 2023;857:159326. [PMID: 36220466 DOI: 10.1016/j.scitotenv.2022.159326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
von Bartheld CS, Wang L. Prevalence of Olfactory Dysfunction with the Omicron Variant of SARS-CoV-2: A Systematic Review and Meta-analysis. medRxiv 2023:2022. [PMID: 36561176 DOI: 10.1101/2022.12.16.22283582] [Reference Citation Analysis]
|
| 27 |
Budd J, Miller BS, Weckman NE, Cherkaoui D, Huang D, Decruz AT, Fongwen N, Han G, Broto M, Estcourt CS, Gibbs J, Pillay D, Sonnenberg P, Meurant R, Thomas MR, Keegan N, Stevens MM, Nastouli E, Topol EJ, Johnson AM, Shahmanesh M, Ozcan A, Collins JJ, Fernandez Suarez M, Rodriguez B, Peeling RW, Mckendry RA. Lateral flow test engineering and lessons learned from COVID-19. Nat Rev Bioeng 2023;1:13-31. [DOI: 10.1038/s44222-022-00007-3] [Reference Citation Analysis]
|
| 28 |
Aganovic A, Cao G, Kurnitski J, Wargocki P. New dose-response model and SARS-CoV-2 quanta emission rates for calculating the long-range airborne infection risk. Build Environ 2023;228:109924. [PMID: 36531865 DOI: 10.1016/j.buildenv.2022.109924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Boukhvalova MS, Mortensen E, Caple J, Joseph J, Sylla F, Kamali A, Stylos D, Lopez D, March T, Byrd KM, Prince GA, Arndt A, Kajon A, Blanco JCG. SARS-CoV-2 infection augments species- and age-specific predispositions in cotton rats. Sci Rep 2023;13:757. [PMID: 36641520 DOI: 10.1038/s41598-022-27328-y] [Reference Citation Analysis]
|
| 30 |
Li X, Sun B, Lyu K, Chen J, Zhang Y, Sun Y, Li C, Sui T, Wang X, Hu Y, Wang Q, Xu D. Research on the relationship between architectural features in northeast China and vertical aerosol transmission of COVID-19. Front Public Health 2022;10:1052610. [PMID: 36711357 DOI: 10.3389/fpubh.2022.1052610] [Reference Citation Analysis]
|
| 31 |
Wu F, Oghuan J, Gitter A, Mena KD, Brown EL. Wide mismatches in the sequences of primers and probes for monkeypox virus diagnostic assays. J Med Virol 2023;95:e28395. [PMID: 36504122 DOI: 10.1002/jmv.28395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Axon CJ, Dingwall R, Evans S, Cassell JA. The Skagit County choir COVID-19 outbreak - have we got it wrong? Public Health 2023;214:85-90. [PMID: 36525760 DOI: 10.1016/j.puhe.2022.11.007] [Reference Citation Analysis]
|
| 33 |
Butowt R, Bilinska K, von Bartheld CS. Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms. Trends Neurosci 2023;46:75-90. [PMID: 36470705 DOI: 10.1016/j.tins.2022.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 34 |
Gunawardana M, Cortez JM Jr, Breslin J, Webster S, Rochman ND, Anton PA, Baum MM. Clinical SARS-CoV-2 Kinetic Profiles Are Dependent on the Viral Strain and Host Vaccination Status. Microbiol Spectr 2022;10:e0446922. [PMID: 36453916 DOI: 10.1128/spectrum.04469-22] [Reference Citation Analysis]
|
| 35 |
Chawla DG, Cappuccio A, Tamminga A, Sealfon SC, Zaslavsky E, Kleinstein SH. Benchmarking transcriptional host response signatures for infection diagnosis. Cell Syst 2022;13:974-988.e7. [PMID: 36549274 DOI: 10.1016/j.cels.2022.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 36 |
Eder J, Bermejo-Jambrina M, Vlaming KE, Kaptein TM, Zaderer V, Kemper EM, Wilflingseder D, Reitsma S, de Bree GJ, Cohn DM, Geijtenbeek TBH. Inhalation of Low Molecular Weight Heparins as Prophylaxis against SARS-CoV-2. mBio 2022;13:e0255822. [PMID: 36326251 DOI: 10.1128/mbio.02558-22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 37 |
Maasoumy B, Ingiliz P, Spinner CD, Cordes C, Stellbrink HJ, Schulze Zur Wiesch J, Schneeweiß SM, Deterding K, Müller T, Kahlhöfer J, Dörge P, von Karpowitz M, Manns MP, Wedemeyer H, Cornberg M; HepNet Acute HCV-V Study Group. Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study. JHEP Rep 2023;5:100650. [PMID: 36852107 DOI: 10.1016/j.jhepr.2022.100650] [Reference Citation Analysis]
|
| 38 |
Khan M, Clijsters M, Choi S, Backaert W, Claerhout M, Couvreur F, Van Breda L, Bourgeois F, Speleman K, Klein S, Van Laethem J, Verstappen G, Dereli AS, Yoo SJ, Zhou H, Dan Do TN, Jochmans D, Laenen L, Debaveye Y, De Munter P, Gunst J, Jorissen M, Lagrou K, Meersseman P, Neyts J, Thal DR, Topsakal V, Vandenbriele C, Wauters J, Mombaerts P, Van Gerven L. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients. Neuron 2022;110:3919-3935.e6. [PMID: 36446381 DOI: 10.1016/j.neuron.2022.11.007] [Reference Citation Analysis]
|
| 39 |
Jin G, Jin LL. Chinese Herbs for Pharyngitis Including COVID-19-Related Sore Throat. Chinese medicine and natural products 2022;02:e185-e192. [DOI: 10.1055/s-0042-1759765] [Reference Citation Analysis]
|
| 40 |
Piggin M, Smith E, Mankone P, Ndegwa L, Gbesemete D, Pristerà P, Bahrami-Hessari M, Johnson H, Catchpole AP, Openshaw PJM, Chiu C, Read RC, Ward H, Barker C. The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemic. Epidemics 2022;41:100626. [PMID: 36088739 DOI: 10.1016/j.epidem.2022.100626] [Reference Citation Analysis]
|
| 41 |
Kandel C, Lee Y, Taylor M, Llanes A, McCready J, Crowl G, Powis J, Li AX, Shigayeva A, Yip L, Katz K, Kozak R, Mubareka S, McGeer A. Viral dynamics of the SARS-CoV-2 Omicron Variant among household contacts with 2 or 3 COVID-19 vaccine doses. J Infect 2022;85:666-70. [PMID: 36283495 DOI: 10.1016/j.jinf.2022.10.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 42 |
Zhao XG, Cao H. Linking research of biomedical datasets. Brief Bioinform 2022;23:bbac373. [PMID: 36151775 DOI: 10.1093/bib/bbac373] [Reference Citation Analysis]
|
| 43 |
Dioverti V, Salto-alejandre S, Haidar G. Immunocompromised Patients with Protracted COVID-19: a Review of “Long Persisters”. Curr Transpl Rep 2022. [DOI: 10.1007/s40472-022-00385-y] [Reference Citation Analysis]
|
| 44 |
Vaira LA, De Riu G, Boscolo-Rizzo P, Hopkins C, Lechien JR. In response to: Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study. J Med Virol 2022;94:5086-7. [PMID: 35831914 DOI: 10.1002/jmv.27999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Vink E, Ho A. SARS-CoV-2: can isolation be limited to those who are truly infectious? Lancet Respir Med 2022;10:1011-3. [PMID: 36228636 DOI: 10.1016/S2213-2600(22)00272-7] [Reference Citation Analysis]
|
| 46 |
Qiu G, Spillmann M, Tang J, Zhao YB, Tao Y, Zhang X, Geschwindner H, Saleh L, Zingg W, Wang J. On-Site Quantification and Infection Risk Assessment of Airborne SARS-CoV-2 Virus Via a Nanoplasmonic Bioaerosol Sensing System in Healthcare Settings. Adv Sci (Weinh) 2022;9:e2204774. [PMID: 36310114 DOI: 10.1002/advs.202204774] [Reference Citation Analysis]
|
| 47 |
Bax A, Shen Y, Kakeshpour T, Fennelly KP. Snoring may transmit infectious aerosols from the upper to the lower respiratory tract. Medical Hypotheses 2022;168:110966. [DOI: 10.1016/j.mehy.2022.110966] [Reference Citation Analysis]
|
| 48 |
Davis EL, Hollingsworth TD. Estimating LFT and qPCR test-sensitivity over time since infection from a human challenge study.. [DOI: 10.1101/2022.10.18.22280274] [Reference Citation Analysis]
|
| 49 |
Heneghan CJ, Spencer EA, Brassey J, Plüddemann A, Onakpoya IJ, Oke JL, Evans DH, Conly JM, Jefferson T. SARS-CoV-2 and the role of airborne transmission: a systematic review. F1000Res 2021;10:232. [DOI: 10.12688/f1000research.52091.3] [Reference Citation Analysis]
|
| 50 |
Adamson PC, Currier JS, Uslan DZ, Garner OB. Prevalence and Factors Associated With Antigen Test Positivity Following SARS-CoV-2 Infection Among Health Care Workers in Los Angeles. Open Forum Infect Dis 2022;9:ofac462. [PMID: 36285175 DOI: 10.1093/ofid/ofac462] [Reference Citation Analysis]
|
| 51 |
Jung J, Kim SK, Lee Y, Park S, Lim YJ, Kim EO, Kim SH. Rates of COVID-19 Infection Among Healthcare Workers in Designated COVID-19 Wards and General Wards. J Korean Med Sci 2022;37:e308. [PMID: 36345254 DOI: 10.3346/jkms.2022.37.e308] [Reference Citation Analysis]
|
| 52 |
Poydenot F, Abdourahamane I, Caplain E, Der S, Haiech J, Jallon A, Khoutami I, Loucif A, Marinov E, Andreotti B. Risk assessment for long- and short-range airborne transmission of SARS-CoV-2, indoors and outdoors. PNAS Nexus 2022;1:pgac223. [PMID: 36712338 DOI: 10.1093/pnasnexus/pgac223] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 53 |
Dove MS, Leistikow BN, Khan N, Tong EK. Current Smoking and Risk of Coronavirus Infection and Illness in a Highly Controlled Challenge Study: A Re-analysis of the British Cold Study. Nicotine Tob Res 2022. [PMID: 36194540 DOI: 10.1093/ntr/ntac148] [Reference Citation Analysis]
|
| 54 |
Marquez C, Kerkhoff AD, Schrom J, Rojas S, Black D, Mitchell A, Wang CY, Pilarowski G, Ribeiro S, Jones D, Payan J, Manganelli S, Rojas S, Lemus J, Jain V, Chamie G, Tulier-Laiwa V, Petersen M, DeRisi J, Havlir DV. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods. JAMA Netw Open 2022;5:e2235844. [PMID: 36215069 DOI: 10.1001/jamanetworkopen.2022.35844] [Reference Citation Analysis]
|
| 55 |
Drain PK, Dalmat RR, Hao L, Bemer MJ, Budiawan E, Morton JF, Ireton RC, Hsiang T, Marfatia Z, Prabhu R, Woosley C, Gichamo A, Rechkina E, Hamilton D, Montaño M, Cantera JL, Ball AS, Golez I, Smith E, Greninger AL, Mcelrath MJ, Thompson M, Grant BD, Meisner A, Gottlieb GS, Gale MJ. Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study.. [DOI: 10.1101/2022.09.26.22280387] [Reference Citation Analysis]
|
| 56 |
Gaskell K, Kheir NE, Mirfendesky M, Rampling T, Marks M, Houlihan CF, Lemonge N, Bristowe H, Aslam S, Kyprianou D, Nastouli E, Goldblatt D, Fielding K, Moore D, CONTACT team (field team). Comparison Of New and emerging SARS-CoV-2 variant Transmissibility through Active Contact Testing. A comparative cross-sectional household seroprevalence study.. [DOI: 10.1101/2022.09.27.22280419] [Reference Citation Analysis]
|
| 57 |
Jamrozik E. Public health ethics: critiques of the "new normal". Monash Bioeth Rev 2022. [PMID: 36167921 DOI: 10.1007/s40592-022-00163-7] [Reference Citation Analysis]
|
| 58 |
Shahbaz MA, De Bernardi F, Alatalo A, Sachana M, Clerbaux L, Muñoz A, Parvatam S, Landesmann B, Kanninen KM, Coecke S. Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework. Cells 2022;11:3027. [DOI: 10.3390/cells11193027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 59 |
Xu J, Carruthers J, Finnie T, Hall I. Simplified Within Host and Dose-response models of SARS-CoV-2.. [DOI: 10.1101/2022.09.20.22279832] [Reference Citation Analysis]
|
| 60 |
Gunawardana M, Cortez J, Breslin J, Webster S, Rochman N, Anton P, Baum M. Clinical SARS-CoV-2 Kinetic Profiles Are Dependent on the Viral Strain and Host Vaccination Status. Res Sq 2022:rs. [PMID: 36172125 DOI: 10.21203/rs.3.rs-1978917/v1] [Reference Citation Analysis]
|
| 61 |
Shrimpton AJ, Pickering AE. Aerosols: time to clear the air? Anaesthesia. [DOI: 10.1111/anae.15864] [Reference Citation Analysis]
|
| 62 |
Onakpoya IJ, Heneghan CJ, Spencer EA, Brassey J, Rosca EC, Maltoni S, Plüddemann A, Evans DH, Conly JM, Jefferson T. Viral Cultures for Assessing Fomite Transmission of SARS-CoV-2: a Systematic Review and Meta-Analysis. J Hosp Infect 2022:S0195-6701(22)00283-3. [PMID: 36115620 DOI: 10.1016/j.jhin.2022.09.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 63 |
Garcia-knight M, Anglin K, Tassetto M, Lu S, Zhang A, Goldberg SA, Catching A, Davidson MC, Shak JR, Romero M, Pineda-ramirez J, Diaz-sanchez R, Rugart P, Donohue K, Massachi J, Sans HM, Djomaleu M, Mathur S, Servellita V, Mcilwain D, Gaudiliere B, Chen J, Martinez EO, Tavs JM, Bronstone G, Weiss J, Watson JT, Briggs-hagen M, Abedi GR, Rutherford GW, Deeks SG, Chiu C, Saydah S, Peluso MJ, Midgley CM, Martin JN, Andino R, Kelly JD. Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study. PLoS Pathog 2022;18:e1010802. [DOI: 10.1371/journal.ppat.1010802] [Reference Citation Analysis]
|
| 64 |
da Silva SJR, do Nascimento JCF, Germano Mendes RP, Guarines KM, Targino Alves da Silva C, da Silva PG, de Magalhães JJF, Vigar JRJ, Silva-Júnior A, Kohl A, Pardee K, Pena L. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infect Dis 2022;8:1758-814. [PMID: 35940589 DOI: 10.1021/acsinfecdis.2c00204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 65 |
Cuthbertson L, Löber U, Ish-horowicz JS, Mcbrien CN, Churchward C, Parker JC, Olanipekun MT, Burke C, O’carroll O, Faul J, Davies GA, Lewis KE, Hopkin JM, Creaser-thomas J, Goshal R, Chung KF, Piatek S, Willis-owen SA, Bartolomaeus TUP, Birkner T, Dwyer S, Kumar N, Turek EM, Musk AW, Hui J, Hunter M, James A, Dumas M, Filippi S, Cox MJ, Lawley TD, Forslund SK, Moffatt MF, Cookson WO. Genomic and ecologic characteristics of the airway microbial-mucosal complex.. [DOI: 10.1101/2022.09.08.507073] [Reference Citation Analysis]
|
| 66 |
Grebennikov D, Karsonova A, Loguinova M, Casella V, Meyerhans A, Bocharov G. Predicting the Kinetic Coordination of Immune Response Dynamics in SARS-CoV-2 Infection: Implications for Disease Pathogenesis. Mathematics 2022;10:3154. [DOI: 10.3390/math10173154] [Reference Citation Analysis]
|
| 67 |
Bigay J, Le Grand R, Martinon F, Maisonnasse P. Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development. Front Microbiol 2022;13:932408. [DOI: 10.3389/fmicb.2022.932408] [Reference Citation Analysis]
|
| 68 |
Matrajt L, Brown ER, Cohen MS, Dimitrov D, Janes H. Could widespread use of antiviral treatment curb the COVID-19 pandemic? A modeling study. BMC Infect Dis 2022;22:683. [PMID: 35945513 DOI: 10.1186/s12879-022-07639-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 69 |
Murakami M, Fujita T, Li P, Imoto S, Yasutaka T. Development of a COVID-19 risk assessment model for participants at outdoor music festivals: evaluation of the validity and control measure effectiveness based on two actual events in Japan and Spain. PeerJ 2022;10:e13846. [PMID: 35966931 DOI: 10.7717/peerj.13846] [Reference Citation Analysis]
|
| 70 |
Chin AWH, Lai AMY, Peiris M, Man Poon LL. Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain. Emerg Infect Dis 2022;28:1515-7. [PMID: 35550234 DOI: 10.3201/eid2807.220428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 71 |
Hakki S, Zhou J, Jonnerby J, Singanayagam A, Barnett JL, Madon KJ, Koycheva A, Kelly C, Houston H, Nevin S, Fenn J, Kundu R, Crone MA, Pillay TD, Ahmad S, Derqui-fernandez N, Conibear E, Freemont PS, Taylor GP, Ferguson N, Zambon M, Barclay WS, Dunning J, Lalvani A, Badhan A, Varro R, Luca C, Quinn V, Cutajar J, Nichols N, Russell J, Grey H, Ketkar A, Miserocchi G, Tejpal C, Catchpole H, Nixon K, Di Biase B, Hopewell T, Narean JS, Samuel J, Timcang K, Mcdermott E, Bremang S, Hammett S, Evetts S, Kondratiuk A. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study. The Lancet Respiratory Medicine 2022. [DOI: 10.1016/s2213-2600(22)00226-0] [Reference Citation Analysis]
|
| 72 |
Jefferson T, Heneghan CJ, Spencer E, Brassey J, Plüddemann A, Onakpoya I, Evans D, Conly J. A Hierarchical Framework for Assessing Transmission Causality of Respiratory Viruses. Viruses 2022;14:1605. [PMID: 35893670 DOI: 10.3390/v14081605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 73 |
Rodriguez J, Price O, Jennings R, Creel A, Eaton S, Chesnutt J, Mcclellan G, Batni SR. A Novel Framework for Modeling Person-to-Person Transmission of Respiratory Diseases. Viruses 2022;14:1567. [DOI: 10.3390/v14071567] [Reference Citation Analysis]
|
| 74 |
Löndahl J, Alsved M. Abrupt decreases in infectivity of SARS-CoV-2 in aerosols. Proc Natl Acad Sci U S A 2022;119:e2208742119. [PMID: 35858364 DOI: 10.1073/pnas.2208742119] [Reference Citation Analysis]
|
| 75 |
Phan T, Brozak S, Pell B, Gitter A, Mena KD, Kuang Y, Wu F. A simple SEIR-V model to estimate COVID-19 prevalence and predict SARS-CoV-2 transmission using wastewater-based surveillance data. medRxiv 2022:2022. [PMID: 35898336 DOI: 10.1101/2022.07.17.22277721] [Reference Citation Analysis]
|
| 76 |
Parhizkar H, Rockcastle S, Fretz M, Van Den Wymelenberg KG. A Simulation-Based Approach To Mitigate Disease Transmission Risk From Aerosol Particles In Buildings. 2022 Annual Modeling and Simulation Conference (ANNSIM) 2022. [DOI: 10.23919/annsim55834.2022.9859484] [Reference Citation Analysis]
|
| 77 |
Winnett AV, Akana R, Shelby N, Davich H, Caldera S, Yamada T, Reyna JRB, Romano AE, Carter AM, Kim MK, Thomson M, Tognazzini C, Feaster M, Goh Y, Chew YC, Ismagilov RF. SARS-CoV-2 exhibits extreme differences in early viral loads among specimen types suggesting improved detection of pre-infectious and infectious individuals using combination specimen types.. [DOI: 10.1101/2022.07.13.22277113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 78 |
Townsley H, Carr EJ, Russell TW, Adams L, Mears HV, Bailey C, Black JR, Fowler AS, Wilkinson K, Hutchinson M, Harvey R, Clayton B, Kelly G, Beale R, Papineni P, Corrah T, Caidan S, Nicod J, Gamblin S, Kassiotis G, Libri V, Williams B, Gandhi S, Kucharski AJ, Swanton C, Wall EC, Bauer DL. Non-hospitalised, vaccinated adults with COVID-19 caused by Omicron BA.1 and BA.2 present with changing symptom profiles compared to those with Delta despite similar viral kinetics.. [DOI: 10.1101/2022.07.07.22277367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 79 |
Adamson PC, Currier JS, Uslan DZ, Garner OB. Prevalence and factors associated with antigen test positivity following SARS-CoV-2 infection among healthcare workers in Los Angeles.. [DOI: 10.1101/2022.07.06.22277341] [Reference Citation Analysis]
|
| 80 |
Wu Z, Wang C, Liu B, Liang C, Lu J, Li J, Tang X, Li C, Li T. Smartphone-Based High-Throughput Fiber-Integrated Immunosensing System for Point-of-Care Testing of the SARS-CoV-2 Nucleocapsid Protein. ACS Sens 2022. [PMID: 35766020 DOI: 10.1021/acssensors.2c00754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 81 |
Shen Y, Courtney JM, Anfinrud P, Bax A. Hybrid measurement of respiratory aerosol reveals a dominant coarse fraction resulting from speech that remains airborne for minutes. Proc Natl Acad Sci U S A 2022;119:e2203086119. [PMID: 35727979 DOI: 10.1073/pnas.2203086119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 82 |
Watson JA, Kissler SM, Day NPJ, Grad YH, White NJ. Characterizing SARS-CoV-2 Viral Clearance Kinetics to Improve the Design of Antiviral Pharmacometric Studies. Antimicrob Agents Chemother 2022;:e0019222. [PMID: 35736134 DOI: 10.1128/aac.00192-22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 83 |
Sette A, Crotty S. Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines. Immunol Rev 2022. [PMID: 35733376 DOI: 10.1111/imr.13089] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 84 |
Yin Y, Xi Y, Xu C, Sun Q. The Basic Reproduction Number and Delayed Action of T Cells for Patients Infected with SARS-CoV-2. Mathematics 2022;10:2017. [DOI: 10.3390/math10122017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 85 |
Baselga M, Güemes A, Alba JJ, Schuhmacher AJ. SARS-CoV-2 Droplet and Airborne Transmission Heterogeneity. JCM 2022;11:2607. [DOI: 10.3390/jcm11092607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 86 |
Wan Z, Lu R, Zhao Y, Zhang C. Diagnostic strategy of SARS-CoV-2 for containment under China's zero-COVID-19 policy. Journal of Infection 2022. [DOI: 10.1016/j.jinf.2022.04.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 87 |
Rohrig A, Eyal N. A new day for human challenge trials? Trends in Molecular Medicine 2022. [DOI: 10.1016/j.molmed.2022.05.002] [Reference Citation Analysis]
|
| 88 |
Miura F, Klinkenberg D, Wallinga J. Dose-response modelling of endemic coronavirus and SARS-CoV-2: human challenge trials reveal the individual variation in susceptibility.. [DOI: 10.1101/2022.04.07.22273549] [Reference Citation Analysis]
|
| 89 |
Fais F, Juskeviciene R, Francardo V, Mateos S, Guyard M, Viollet C, Constant S, Borelli M, Hohenfeld IP. Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia. Int J Mol Sci 2022;23:4062. [PMID: 35409423 DOI: 10.3390/ijms23074062] [Reference Citation Analysis]
|
| 90 |
Acker ID, Ware MJ, Bracht JR. Surface detection of SARS-CoV-2 by lateral flow LAMP.. [DOI: 10.1101/2022.04.04.487067] [Reference Citation Analysis]
|
| 91 |
Ganti K, Ferreri LM, Lee CY, Bair CR, Delima GK, Holmes KE, Suthar MS, Lowen AC. Timing of exposure is critical in a highly sensitive model of SARS-CoV-2 transmission. PLoS Pathog 2022;18:e1010181. [PMID: 35333914 DOI: 10.1371/journal.ppat.1010181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 92 |
Diniz MO, Mitsi E, Swadling L, Rylance J, Johnson M, Goldblatt D, Ferreira D, Maini MK. Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2. Nat Immunol 2022;23:1324-9. [PMID: 36038709 DOI: 10.1038/s41590-022-01292-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
